| U.S. Brand Names |
| Degas®[OTC]; Flatulex®[OTC]; Gas Relief®; Gas-X®[OTC]; Maalox® Anti-Gas [OTC]; Mylanta® Gas [OTC]; Mylicon®[OTC]; Phazyme®[OTC] |
 |
| Generic Available |
|
Yes: Tablet |
|
| Synonyms |
| Activated Dimethicone; Activated Methylpolysiloxane |
|
| Pharmacological Index |
|
Antiflatulent |
|
| Use |
|
Relieves flatulence and functional gastric bloating, and postoperative gas pains |
|
| Pregnancy Risk Factor |
|
C |
|
| Contraindications |
|
Hypersensitivity to simethicone or any component |
|
| Adverse Reactions |
|
No data reported |
|
| Drug Interactions |
|
No data reported |
|
| Stability |
|
Protect from light |
|
| Mechanism of Action |
|
Decreases the surface tension of gas bubbles thereby disperses and prevents gas pockets in the GI system |
|
| Usual Dosage |
|
Oral: Children <12 years: 40 mg 4 times/day Children >12 years and Adults: 40-120 mg after meals and at bedtime as needed, not to exceed 500 mg/day |
|
| Dietary Considerations |
|
Avoid carbonated beverages and gas-forming foods; should be administered after meals |
|
| Administration |
|
Shake suspension before using; mix with water, infant formula, or other liquids |
|
| Mental Health: Effects on Mental Status |
|
None reported |
|
| Mental Health: Effects on Psychiatric Treatment |
|
None reported |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
Some tablets may be chewed thoroughly before swallowing, follow with a glass of water |
|
| Nursing Implications |
|
Shake suspension before using; mix with water, infant formula or other liquids |
|
| Dosage Forms |
|
Capsule: 125 mg Drops, oral: 40 mg/0.6 mL (30 mL) Tablet: 50 mg, 60 mg, 95 mg Chewable: 40 mg, 80 mg, 125 mg |
|
|
Copyright © 2007 Drugs Area |
